The ER stress pathway has previously been linked to diabetic neuropathy in rodents, where administering an sEH inhibitor alleviated neuropathic pain and decreased ATF4 and activating transcription factor 6 mRNA levels (39), suggesting potential crosstalk between ER stress and sEH pathways in diabetic complications. This evidence concerns the gene TFAM and diabetic neuropathy.